SMMT financials
Summit Therapeutics (SMMT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SMMT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$1.09B | -$1.08B | -1.44 |
| 2024 | $0.00 | $0.00 | -$180.51M | -$176.77M | -0.25 |
| 2023 | $0.00 | $0.00 | -$478.23M | -$482.37M | -0.78 |
| 2022 | $583.19K | $583.19K | -$59.63M | -$65.17M | -0.34 |
| 2021 | $1.34M | $1.34M | -$63.73M | -$65.52M | -0.71 |
| 2020 | $628.88K | $628.88K | -$71.65M | -$38.53M | -0.56 |